CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Purchases, (Sales), Issuances, (Settlements) (Deprecated 2019-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Purchases, (Sales), Issuances, (Settlements) (Deprecated 2019-01-31) of $8.96 million for the 12-month period ending 2013-12-28, per its 10-K filed 2014-02-25.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityPurchasesSalesIssuesSettlements · last filed 2014-02-25
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, instruments classified in shareholders' equity, purchases, (sales), issuances, (settlements) (deprecated 2019-01-31) for fiscal 2013 was $8.96M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Purchases, (Sales), Issuances, (Settlements) (Deprecated 2019-01-31) 12 month |
|---|---|
| 2013-12-28 | $8.96M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |